Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Cervical Cancer

  Free Subscription

Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 110 articles:
HTML format

Single Articles

    June 2024
  1. WANG R, Ma L, Xiao Y, Jiang H, et al
    A case of postoperative non-invasive mucosal implantation of early-stage cervical adenocarcinoma to the clitoris.
    Int J Gynaecol Obstet. 2024;165:1295-1297.

    May 2024
  2. YANG ST, Liu HH, Liu CH, Wang LW, et al
    Bevacizumab is associated with a higher gastrointestinal/genitourinary fistula or perforation risk in cervical cancer patients undergoing pelvic radiotherapy.
    Int J Gynaecol Obstet. 2024 May 15. doi: 10.1002/ijgo.15609.
    PubMed     Abstract available

  3. MWANDACHA N, Dau H, AboMoslim M, Naguti P, et al
    Investigating the healthcare-seeking behaviors of mobile phone users to improve cervical cancer screening in rural Uganda.
    Int J Gynaecol Obstet. 2024 May 4. doi: 10.1002/ijgo.15577.
    PubMed     Abstract available

    April 2024
  4. ALFAREH M, Obeid D, Alhoshan H, Basri R, et al
    Low uptake of Pap test as a cervical cancer screen among Saudi women: Findings from a national survey.
    Int J Gynaecol Obstet. 2024 Apr 19. doi: 10.1002/ijgo.15532.
    PubMed     Abstract available

  5. PATEL A, Suneja A, Malik R, Gupta B, et al
    Chromocolposcopy with fluorescein sodium for detection of premalignant and malignant lesions of the cervix: A cross-sectional study.
    Int J Gynaecol Obstet. 2024;165:169-175.
    PubMed     Abstract available

    March 2024
  6. XU JY, Hu M, Wu SG, Zhou J, et al
    Local treatment strategies in Stage IVB cervical squamous cell carcinoma and adenocarcinoma.
    Int J Gynaecol Obstet. 2024;164:1053-1063.
    PubMed     Abstract available

  7. STRATULAT V, Melamed N, Barrett J, Ladhani NNN, et al
    Cervical assessment certification and its impact on performance quality in the context of universal cervical screening.
    Int J Gynaecol Obstet. 2024;164:951-958.
    PubMed     Abstract available

    February 2024
  8. MARINO-NOYA A, Magallanes-Pelaez N, Puga-Gonzalez N, Conde-Ferreiros M, et al
    Cervical carcinosarcoma, report of some cases and a literature review.
    Int J Gynaecol Obstet. 2024;164:795-796.

  9. JIA L, Wang L, Zheng J, Lu J, et al
    Ureter metastasis from a primary cervical malignancy 3 years after initial treatment.
    Int J Gynaecol Obstet. 2024;164:793-794.

    January 2024
  10. SABEENA S, Ravishankar N, Kalpana MM
    Implementation strategies of cervical cancer screening in South Asia: A systematic review.
    Int J Gynaecol Obstet. 2024 Jan 24. doi: 10.1002/ijgo.15366.
    PubMed     Abstract available

  11. VAN DE SANDE AJM, Kengsakul M, Koeneman MM, Jozwiak M, et al
    The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2024;164:66-74.
    PubMed     Abstract available

    December 2023
  12. TANG X, Zhang X, Ding Y, Zhang Y, et al
    A long-term retrospective analysis of management of cervical cancer during pregnancy.
    Int J Gynaecol Obstet. 2023 Dec 27. doi: 10.1002/ijgo.15314.
    PubMed     Abstract available

  13. DESRAVINES N, Hsu CH, Mohnot S, Sahasrabuddhe V, et al
    Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
    Int J Gynaecol Obstet. 2023;163:862-867.
    PubMed     Abstract available

    November 2023
  14. ZHANG Y, Wang C, Zhao Z, Cheng L, et al
    Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
    Int J Gynaecol Obstet. 2023 Nov 11. doi: 10.1002/ijgo.15218.
    PubMed     Abstract available

  15. LUCKETT R, Ramogola-Masire D, Gompers A, Moraka N, et al
    Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana.
    Int J Gynaecol Obstet. 2023 Nov 10. doi: 10.1002/ijgo.15225.
    PubMed     Abstract available

  16. HILL SK, Bempong-Ahun N, Okolo ID, Lalla AT, et al
    Improving access to safe, quality surgical care for gynecologic cancers through capacity-building interventions in low- and middle-income countries: A scoping review.
    Int J Gynaecol Obstet. 2023 Nov 5. doi: 10.1002/ijgo.15156.
    PubMed     Abstract available

  17. RAMESAN CK, Calvin JD, Thomas A, Fletcher J, et al
    Diagnostic study of human papillomavirus DNA detection in cervical and vaginal samples using the filter paper card.
    Int J Gynaecol Obstet. 2023;163:660-666.
    PubMed     Abstract available

    October 2023
  18. VARGAS-CARDONA HD, Rodriguez-Lopez M, Arrivillaga M, Vergara-Sanchez C, et al
    Artificial intelligence for cervical cancer screening: Scoping review, 2009-2022.
    Int J Gynaecol Obstet. 2023 Oct 9. doi: 10.1002/ijgo.15179.
    PubMed     Abstract available

  19. REIJNTJES B, Eising M, Kleppe M, Geuken E, et al
    The clinical relevance of excisional margins after large loop excision of the transformation zone for the persistence of cervical dysplasia.
    Int J Gynaecol Obstet. 2023;163:140-147.
    PubMed     Abstract available

  20. HAMAR B, Teutsch B, Hoffmann E, Hegyi P, et al
    Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: A systematic review and meta-analysis of 470 000 patients.
    Int J Gynaecol Obstet. 2023;163:31-43.
    PubMed     Abstract available

    September 2023
  21. LIU Y, He J, Liu P, Chen C, et al
    Postoperative management of FIGO 2018 stage IIA1 cervical squamous cell carcinoma with only one intermediate-risk factor: Is radiotherapy needed?
    Int J Gynaecol Obstet. 2023;162:1098-1105.
    PubMed     Abstract available

  22. ZHOU Y, Wang C, Li W, Lu W, et al
    Fluorescence colposcope with TMTP1-PEG4-ICG is comparable to the conventional colposcope in identifying cervical precancerous lesions: A randomized controlled trial.
    Int J Gynaecol Obstet. 2023;162:969-976.
    PubMed     Abstract available

    July 2023
  23. AMARAL E, Cain JM, Hearing F, Lumsden MA, et al
    FIGO guidance for sustainable implementation of vaccination programs for women: Pregnancy and HPV.
    Int J Gynaecol Obstet. 2023;162 Suppl 1:3-23.

    June 2023
  24. BONI SP, Horo A, Didi-Kouko-Coulibaly J, Tanon A, et al
    Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Cote d'Ivoire: A prospective cohort study.
    Int J Gynaecol Obstet. 2023 Jun 22. doi: 10.1002/ijgo.14925.
    PubMed     Abstract available

  25. KASUGA Y, Hasegawa K, Hamuro A, Fukuma Y, et al
    Pregnancy outcomes following radical trachelectomy for early-stage cervical cancer: A retrospective observational study in the Kanto area, Japan.
    Int J Gynaecol Obstet. 2023 Jun 21. doi: 10.1002/ijgo.14935.
    PubMed     Abstract available

  26. TOGAMI S, Tokudome A, Fukuda M, Mizuno M, et al
    Validation of single-photon emission computed tomography with computed tomography and lymphoscintigraphy for sentinel lymph node identification in cervical cancer.
    Int J Gynaecol Obstet. 2023 Jun 18. doi: 10.1002/ijgo.14917.
    PubMed     Abstract available

    May 2023
  27. DE LA CRUZ-RAMIREZ YM, Olaza-Maguina AF
    Barriers to HPV vaccine uptake in adolescents of the indigenous Andean community of Peru.
    Int J Gynaecol Obstet. 2023 May 5. doi: 10.1002/ijgo.14844.

    April 2023
  28. GIANNELLA L, Delli Carpini G, Di Giuseppe J, Gardella B, et al
    Should attention be paid to the cone depth in the fully visible transformation zone? Retrospective analysis of 517 patients with cervical intraepithelial neoplasia grade 3.
    Int J Gynaecol Obstet. 2023;161:137-143.
    PubMed     Abstract available

  29. TEHRANIAN A, Ghahghaei-Nezamabadi A, Seifollahi A, Mansouri P, et al
    Concurrent anorectal and cervical cytology in women with positive and negative cervical smear test results: A cross-sectional study.
    Int J Gynaecol Obstet. 2023;161:100-105.
    PubMed     Abstract available

    March 2023
  30. YANG S, Zhao J, Zhao H, Hu Y, et al
    Development of a nomogram for predicting pelvic lymph node metastasis in cervical squamous cell carcinoma.
    Int J Gynaecol Obstet. 2023;160:1020-1027.
    PubMed     Abstract available

    February 2023
  31. MCCLYMONT E, Money D
    The shift to one-dose HPV vaccination: Where does this leave women living with HIV?
    Int J Gynaecol Obstet. 2023 Feb 20. doi: 10.1002/ijgo.14713.

  32. DING T, Li L, Duan R, Chen Y, et al
    Risk factors analysis of recurrent disease after treatment with a loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2023;160:538-547.
    PubMed     Abstract available

    January 2023
  33. XIAO SY, Major CK, O'Connell KA, Lee D, et al
    Breast and Cervical Cancer Screening Rates in Student-Run Free Clinics: A Systematic Review.
    Int J Gynaecol Obstet. 2023 Jan 16. doi: 10.1002/ijgo.14675.
    PubMed     Abstract available

  34. MARQUES LS, Violin VGA, Meireles LEF, de Souza MVF, et al
    Kin17 high expression as a potential biomarker for high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2023;160:339-341.

    December 2022
  35. LEVIN G, Cohen L, Brandt B, Kogan L, et al
    Ethnical disparity in cervical cancer stage at diagnosis - a retrospective study in Israeli referral-center.
    Int J Gynaecol Obstet. 2022 Dec 24. doi: 10.1002/ijgo.14644.
    PubMed     Abstract available

  36. MATSUO K, Violette CJ, Mandelbaum RS, Shoupe D, et al
    Utilizations and characteristics of ovarian conservation at hysterectomy for cervical carcinoma in-situ.
    Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14604.
    PubMed     Abstract available

    November 2022
  37. BAO H, Zhao Y, Zhang X, Bi H, et al
    HPV-negative high-grade cervical precancerous lesions or invasive cancer in China: A post hoc analysis of a multicentric clinical study.
    Int J Gynaecol Obstet. 2022 Nov 29. doi: 10.1002/ijgo.14598.
    PubMed     Abstract available

    October 2022
  38. REIS BS, Nogueira CM, Meneses AFP, Mellado BH, et al
    Experiences of women with advanced cervical cancer before starting the treatment: Systematic review of qualitative studies.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14491.
    PubMed     Abstract available

  39. SEOUD M, Jaafar I, Hamadeh R, Ammar W, et al
    Feasibility of Implementing Cytology Based Cervical Cancer Screening National Program in Lebanon: A pilot Study.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14489.
    PubMed     Abstract available

  40. JOHN JH, Halder A, Purwar S, Pushpalatha K, et al
    Study to determine efficacy of Urinary HPV 16 &18 detection in predicting premalignant and malignant lesions of Uterine Cervix.
    Int J Gynaecol Obstet. 2022 Oct 2. doi: 10.1002/ijgo.14486.
    PubMed     Abstract available

    September 2022
  41. DE CARVALHO CF, da Costa LBE, de Moraes Sanches NCC, Damas II, et al
    Prognosis determination of Endocervical Adenocarcinomas morphologically reclassified in HPV associated or HPV Independent.
    Int J Gynaecol Obstet. 2022 Sep 8. doi: 10.1002/ijgo.14442.
    PubMed     Abstract available

  42. MAILLIE L, Yussuph A, Chirangi B, Schroeder K, et al
    Outcomes From Eight Years of Cervical Cancer Screening at a Rural Screen-and-Treat Site in Northern Tanzania.
    Int J Gynaecol Obstet. 2022 Sep 2. doi: 10.1002/ijgo.14429.
    PubMed     Abstract available

  43. VORA KS, Saiyed S, Joshi R, Natesan S, et al
    Prevalence of High Risk HPV amongst marginalized urban women in India and its implications on vaccination: A cross sectional study.
    Int J Gynaecol Obstet. 2022 Sep 1. doi: 10.1002/ijgo.14428.
    PubMed     Abstract available

    August 2022
  44. DAU H, Trawin J, Nakisige C, Payne BA, et al
    The social and economic impacts of cervical cancer on women and children in low- and middle-income countries: a systematic review.
    Int J Gynaecol Obstet. 2022 Aug 13. doi: 10.1002/ijgo.14395.
    PubMed     Abstract available

    July 2022
  45. HU SY, Zhao XL, Zhao FH, Wei LH, et al
    Implementation of Visual Inspection with Acetic Acid and Lugol's Iodine for Cervical Cancer Screening in Rural China.
    Int J Gynaecol Obstet. 2022 Jul 24. doi: 10.1002/ijgo.14368.
    PubMed     Abstract available

    June 2022
  46. FRICK A, Azuaga A, Abdulcadir J
    Cervical dysplasia among migrant women with female genital mutilation/cutting type III: A cross-sectional study.
    Int J Gynaecol Obstet. 2022;157:557-563.
    PubMed     Abstract available

    April 2022
  47. CIAVATTINI A, Di Giuseppe J, Marconi C, Giannella L, et al
    Hysterectomy for cervical intraepithelial neoplasia: A Retrospective observational multi-institutional study.
    Int J Gynaecol Obstet. 2022 Apr 27. doi: 10.1002/ijgo.14233.
    PubMed     Abstract available

  48. THIANGPHAK E, Pruegsanusak K, Buhachat R
    Pretreatment lymphocyte count as independent prognostic factor in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Int J Gynaecol Obstet. 2022 Apr 23. doi: 10.1002/ijgo.14229.
    PubMed     Abstract available

  49. GUO X, Tian S, Wang H, Zhang J, et al
    Outcomes associated with different surgical approaches to radical hysterectomy: A systematic review and network meta-analysis.
    Int J Gynaecol Obstet. 2022 Apr 4. doi: 10.1002/ijgo.14209.
    PubMed     Abstract available

    February 2022
  50. TAWIAH A, Konney TO, Dassah ET, Visser LE, et al
    Determinants of Cervical Cancer Screening Uptake Among Women with Access to Free Screening: A Community-Based Study in Peri-Urban Ghana.
    Int J Gynaecol Obstet. 2022 Feb 25. doi: 10.1002/ijgo.14158.
    PubMed     Abstract available

  51. ZHANG Y, Huang Y, Luo S, Li L, et al
    Therapeutic strategy analysis of patients with advanced stage high-grade neuroendocrine cervical cancer: A real-world multicenter study.
    Int J Gynaecol Obstet. 2022 Feb 5. doi: 10.1002/ijgo.14125.
    PubMed     Abstract available

    January 2022
  52. SETIAWAN D, Miranti I, Partiwi TD, Puspitasari DA, et al
    The Willingness of Cervical Cancer Screening Among Sexually Active Women in Indonesia: Lesson Learned from 2 Districts.
    Int J Gynaecol Obstet. 2022 Jan 25. doi: 10.1002/ijgo.14113.
    PubMed     Abstract available

  53. FU K, Lei M, Yang WQ, Wu LS, et al
    The treatment strategy of patients with positive margins after cervical cold knife conization-A 7-year retrospective study in China.
    Int J Gynaecol Obstet. 2022;156:159-165.
    PubMed     Abstract available

    December 2021
  54. RAMIREZ M, de la Fuente J, Andia D, Hernandez JJ, et al
    "HPV vaccination coverage in women between 15-55 years in Spain. Temporal trend during the period 2007-2020".
    Int J Gynaecol Obstet. 2021 Dec 14. doi: 10.1002/ijgo.14067.

  55. AYDIN S, Karasu AFG, Marasli M, Bademler N, et al
    Reliability and diagnostic performance of smartphone colposcopy.
    Int J Gynaecol Obstet. 2021;155:404-410.
    PubMed     Abstract available

    November 2021
  56. TU Y, Jiang P, Zhang J, Jiang S, et al
    The positive threshold of the immunohistochemical parameter Ki67 for predicting the recurrence of cervical cancer.
    Int J Gynaecol Obstet. 2021 Nov 4. doi: 10.1002/ijgo.14005.
    PubMed     Abstract available

    October 2021
  57. BISPO PEREIRA EH, Camilo-Junior DJ, D'avilla SCGP, Mattar NJ, et al
    Comparison of Cervical Cancer Screening Results Among Public and Private Services in Brazil.
    Int J Gynaecol Obstet. 2021 Oct 16. doi: 10.1002/ijgo.13985.
    PubMed     Abstract available

  58. OISHI T, Kigawa J, Iwanari O, Kasai T, et al
    Is cytology/HPV co-testing for cervical cancer screening useful in Japan?
    Int J Gynaecol Obstet. 2021 Oct 4. doi: 10.1002/ijgo.13961.
    PubMed     Abstract available

  59. WILAILAK S, Kengsakul M, Kehoe S
    Worldwide initiatives to eliminate cervical cancer.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:102-106.
    PubMed     Abstract available

  60. WICHMANN IA, Cuello MA
    Obesity and gynecological cancers: A toxic relationship.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:123-134.
    PubMed     Abstract available

  61. BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al
    Cancer of the cervix uteri: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:28-44.
    PubMed     Abstract available

  62. RANDALL TC, Somashekhar SP, Chuang L, Ng JS, et al
    Reaching the women with the greatest needs: Two models for initiation and scale-up of gynecologic oncology fellowship trainings in low-resource settings.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:115-122.
    PubMed     Abstract available

  63. ADAMS TS, Rogers LJ, Cuello MA
    Cancer of the vagina: 2021 update.
    Int J Gynaecol Obstet. 2021;155 Suppl 1:19-27.
    PubMed     Abstract available

    September 2021
  64. SANCHEZ-CUERDA C, Cuadra M, Gamir S, Lobo P, et al
    Cervical adenocarcinoma in situ during pregnancy and subsequent fertility-sparing therapy challenge.
    Int J Gynaecol Obstet. 2021 Sep 24. doi: 10.1002/ijgo.13948.
    PubMed     Abstract available

  65. DICK A, Holyk T, Taylor D, Wenninger C, et al
    Highlighting strengths and resources that increase ownership of cervical cancer screening for Indigenous communities in Northern British Columbia: Community-driven approaches.
    Int J Gynaecol Obstet. 2021 Sep 8. doi: 10.1002/ijgo.13915.
    PubMed     Abstract available

  66. NKWABONG E, Kengne B, Nkene Mawamba Y, Sando Z, et al
    Influence of the human immunodeficiency virus on cervical precancerous lesions.
    Int J Gynaecol Obstet. 2021;154:540-543.
    PubMed     Abstract available

  67. JELINEK K, Harding L, Briceno R, Li Z, et al
    Prevalence of high-risk human papillomavirus genotypes in two regions of Peru.
    Int J Gynaecol Obstet. 2021;154:544-549.
    PubMed     Abstract available

    August 2021
  68. ADCOCK A, Stevenson K, Cram F, MacDonald EJ, et al
    He Tapu Te Whare Tangata (sacred house of humanity): Under-screened Maori women talk about HPV self-testing cervical screening clinical pathways.
    Int J Gynaecol Obstet. 2021 Aug 11. doi: 10.1002/ijgo.13873.
    PubMed     Abstract available

  69. CHO HW, Hong JH, Lee JK
    Detection of high-risk human papillomavirus infection and treatment of high-grade vaginal intraepithelial neoplasia: A single-institution study.
    Int J Gynaecol Obstet. 2021;154:227-232.
    PubMed     Abstract available

    July 2021
  70. MUNGO C, Randa M, Shauri A, Serem D, et al
    Characteristics, stage at presentation, and status of women with cervical cancer at a major referral center in western Kenya.
    Int J Gynaecol Obstet. 2021 Jul 20. doi: 10.1002/ijgo.13831.
    PubMed     Abstract available

  71. MWANAHAMUNTU M, Kapambwe S, Pinder LF, Matambo J, et al
    The use of thermal ablation in diverse cervical cancer 'screen-and-treat' service platforms in Zambia.
    Int J Gynaecol Obstet. 2021 Jul 1. doi: 10.1002/ijgo.13808.
    PubMed     Abstract available

  72. MAHANDE MJ, Oneko O, Amour C, Pollie M, et al
    Feasibility and acceptability of human papillomavirus self-sampling in a semi-urban area in northern Tanzania.
    Int J Gynaecol Obstet. 2021;154:113-118.
    PubMed     Abstract available

    June 2021
  73. YU Y, Deng T, Gu S
    Minimally invasive surgery and abdominal radical hysterectomy in patients with early-stage cervical cancer: A meta-analysis.
    Int J Gynaecol Obstet. 2021 Jun 24. doi: 10.1002/ijgo.13796.
    PubMed     Abstract available

  74. TREJO MJ, Soliman AS, Chen Y, Kalima M, et al
    Effects of HIV infection on metastatic cervical cancer and age at diagnosis among patients in Lusaka, Zambia.
    Int J Gynaecol Obstet. 2021 Jun 14. doi: 10.1002/ijgo.13784.
    PubMed     Abstract available

    May 2021
  75. TESKERECI G, Arslan UO, Oncel S
    The awareness levels of women on gynecological cancer in Turkey: A cross-sectional study.
    Int J Gynaecol Obstet. 2021 May 18. doi: 10.1002/ijgo.13745.
    PubMed     Abstract available

  76. SOFTELAND S, Sebitloane MH, Taylor M, Roald BB, et al
    A systematic review of handheld tools in lieu of colposcopy for cervical neoplasia and female genital schistosomiasis.
    Int J Gynaecol Obstet. 2021;153:190-199.
    PubMed     Abstract available

    April 2021
  77. DORJI T, Tshomo U, Gyamtsho S, Tamang ST, et al
    Gender-neutral HPV elimination, cervical cancer screening, and treatment: Experience from Bhutan.
    Int J Gynaecol Obstet. 2021 Apr 30. doi: 10.1002/ijgo.13728.
    PubMed     Abstract available

    March 2021
  78. KEMPER KE, McGrath CJ, Eckert LO, Kinuthia J, et al
    Correlates of cervical cancer screening among women living with HIV in Kenya: A cross-sectional study.
    Int J Gynaecol Obstet. 2021 Mar 30. doi: 10.1002/ijgo.13690.
    PubMed     Abstract available

  79. AGAROSSI A, Delli Carpini G, Sopracordevole F, Serri M, et al
    High-risk HPV positivity is a long-term risk factor for recurrence after cervical excision procedure in women living with HIV.
    Int J Gynaecol Obstet. 2021 Mar 15. doi: 10.1002/ijgo.13674.
    PubMed     Abstract available

    February 2021
  80. TANG X, Qiu J, Guo C, Guo J, et al
    A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: A large multicenter study.
    Int J Gynaecol Obstet. 2021 Feb 15. doi: 10.1002/ijgo.13644.
    PubMed     Abstract available

  81. MARINGA VD, Chikandiwa A, Gilham C, Mbodi L, et al
    Performance of the Swede score to predict cervical intraepithelial neoplasia in women with HIV-1 in Johannesburg, South Africa.
    Int J Gynaecol Obstet. 2021;152:188-195.
    PubMed     Abstract available

    January 2021
  82. KRAMER J
    Eradicating cervical cancer: Lessons learned from Rwanda and Australia.
    Int J Gynaecol Obstet. 2021 Jan 17. doi: 10.1002/ijgo.13601.
    PubMed     Abstract available

  83. TAMAUCHI S, Kajiyama H, Osuka S, Moriyama Y, et al
    Reduced response to controlled ovarian stimulation after radical trachelectomy: A pitfall of fertility-sparing surgery for cervical cancer.
    Int J Gynaecol Obstet. 2021 Jan 13. doi: 10.1002/ijgo.13529.
    PubMed     Abstract available

  84. CHUNG MH, De Vuyst H, Greene SA, Topazian HM, et al
    Loop electrosurgical excision procedure (LEEP) plus top hat for HIV-infected women with endocervical intraepithelial neoplasia in Kenya.
    Int J Gynaecol Obstet. 2021;152:118-124.
    PubMed     Abstract available

  85. LIU P, Dai E, Li W, He F, et al
    Effect of pre-operative radiotherapy on long-term outcomes among women with Stage IB1 to IIB cervical squamous cell carcinoma.
    Int J Gynaecol Obstet. 2021;152:125-132.
    PubMed     Abstract available

  86. BUSS LF, Levi JE, Longatto-Filho A, Cohen DD, et al
    Attendance for diagnostic colposcopy among high-risk human papillomavirus positive women in a Brazilian feasibility study.
    Int J Gynaecol Obstet. 2021;152:72-77.
    PubMed     Abstract available

  87. LI Y, Wang H, Zhang Y, Jing X, et al
    Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade.
    Int J Gynaecol Obstet. 2021;152:96-102.
    PubMed     Abstract available

  88. YANG Y, Hu T, Ming X, Yang E, et al
    REBACIN(R) is an optional intervention for persistent high-risk human papillomavirus infection: A retrospective analysis of 364 patients.
    Int J Gynaecol Obstet. 2021;152:82-87.
    PubMed     Abstract available

    December 2020
  89. KIM MH, Jung HJ, Park SI, Kim BJ, et al
    Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Int J Gynaecol Obstet. 2020 Dec 23. doi: 10.1002/ijgo.13574.
    PubMed     Abstract available

  90. TEIXEIRA JC, Santos DZ, Campos CS, Vale DB, et al
    Cervical cancer in women under 25 years of age and outside the screening age: Diagnosis profile and long-term outcomes.
    Int J Gynaecol Obstet. 2020 Dec 20. doi: 10.1002/ijgo.13553.
    PubMed     Abstract available

    WHO global strategy to eliminate cervical cancer as a public health problem: An opportunity to make it a disease of the past.
    Int J Gynaecol Obstet. 2020 Dec 2. doi: 10.1002/ijgo.13484.

    November 2020
  92. BHATLA N, Nessa A, Oswal K, Vashist S, et al
    Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India.
    Int J Gynaecol Obstet. 2020 Nov 18. doi: 10.1002/ijgo.13486.
    PubMed     Abstract available

  93. ROHNER E, Mulongo M, Pasipamire T, Oberlin AM, et al
    Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africa.
    Int J Gynaecol Obstet. 2020 Nov 14. doi: 10.1002/ijgo.13485.
    PubMed     Abstract available

  94. ALLENDE-PEREZ S, Dominguez-Ocadio G, Velez-Salas V, Isla D, et al
    Snapshot of symptoms of advanced cervical cancer patients referred to the palliative care service in a cancer center in Mexico.
    Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13479.
    PubMed     Abstract available

  95. KUMAR S, Khanduri A, Sidibe A, Morgan C, et al
    Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13482.
    PubMed     Abstract available

  96. KENGSAKUL M, Laowahutanont P, Wilailak S
    Experiences in the prevention and screening of cervical cancer within Thailand.
    Int J Gynaecol Obstet. 2020 Nov 12. doi: 10.1002/ijgo.13481.
    PubMed     Abstract available

    A perspective on cervical cancer prevention and screening in Africa.
    Int J Gynaecol Obstet. 2020 Nov 6. doi: 10.1002/ijgo.13476.
    PubMed     Abstract available

  98. SHOU H, Yasuo Y, Yuan S, Lou H, et al
    Association of pretreatment SUVmax of cervix and SCC-antigen with FIGO2018 stage in Stage IIB-IVB squamous cervical cancer and relationship to prognosis.
    Int J Gynaecol Obstet. 2020 Nov 3. doi: 10.1002/ijgo.13465.
    PubMed     Abstract available

  99. DANIEL GO, Musa J, Akindigh TM, Shinku F, et al
    Prevalence and predictors of precancerous cervical lesions among HIV-positive women in Jos, north-central Nigeria.
    Int J Gynaecol Obstet. 2020;151:253-259.
    PubMed     Abstract available

    October 2020
  100. RAWAT A, Sanders C, Mithani N, Amuge C, et al
    Acceptability and preferences for self-collected screening for cervical cancer within health systems in rural Uganda: A mixed-methods approach.
    Int J Gynaecol Obstet. 2020 Oct 31. doi: 10.1002/ijgo.13454.
    PubMed     Abstract available

  101. VALE DB, Teixeira JC, Braganca JF, Derchain S, et al
    Elimination of cervical cancer in low- and middle-income countries: Inequality of access and fragile healthcare systems.
    Int J Gynaecol Obstet. 2020 Oct 31. doi: 10.1002/ijgo.13458.
    PubMed     Abstract available

  102. MAGDI R, Elshafeey F, Elshebiny M, Kamel M, et al
    A systematic review and meta-analysis of diagnostic accuracy of HPV tests for the screening of cervical cancer in low-resource settings.
    Int J Gynaecol Obstet. 2020 Oct 30. doi: 10.1002/ijgo.13455.
    PubMed     Abstract available

  103. OKADOME M, Nagayama R, Shimokawa M, Sonoda K, et al
    Prognosis of bulky pT2b cervical cancer treated by radical hysterectomy comparing adenocarcinoma with squamous cell carcinoma using propensity score matching.
    Int J Gynaecol Obstet. 2020 Oct 29. doi: 10.1002/ijgo.13451.
    PubMed     Abstract available

  104. LAWAL IK, Suleiman AK, Bagudu Z, Kanmodi KK, et al
    Planning and advocating for cervical cancer prevention in Kebbi State, Nigeria: Learning points for the global call to eliminate cervical cancer.
    Int J Gynaecol Obstet. 2020 Oct 8. doi: 10.1002/ijgo.13414.
    PubMed     Abstract available

  105. YIM ET, Rogers TB, Msami K, Calixte R, et al
    Factors related to completion of referral among women with suspected cervical cancer and dysplasia in Tanzania.
    Int J Gynaecol Obstet. 2020 Oct 6. doi: 10.1002/ijgo.13412.
    PubMed     Abstract available

    September 2020
  106. HOQUE MR, Haque E, Karim MR
    Cervical cancer in low-income countries: A Bangladeshi perspective.
    Int J Gynaecol Obstet. 2020 Sep 28. doi: 10.1002/ijgo.13400.
    PubMed     Abstract available

    July 2020
  107. ORANG'O EO, Emont JP, Ermel AC, Liu T, et al
    Detection of types of HPV among HIV-infected and HIV-uninfected Kenyan women undergoing cryotherapy or loop electrosurgical excision procedure.
    Int J Gynaecol Obstet. 2020 Jul 26. doi: 10.1002/ijgo.13330.
    PubMed     Abstract available

    June 2020
  108. RODRIGUEZ J, Fletcher A, Heredia F, Fernandez R, et al
    Alternative management for gynecological cancer care during the COVID-2019 pandemic: A Latin American survey.
    Int J Gynaecol Obstet. 2020 Jun 11. doi: 10.1002/ijgo.13272.
    PubMed     Abstract available

    April 2020
  109. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
    Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination.
    Int J Gynaecol Obstet. 2020 Apr 27. doi: 10.1002/ijgo.13185.
    PubMed     Abstract available

    February 2020
  110. TIMOTEO-LIAINA I, Khozaim K, Chen YA, Buenconsejo-Lum L, et al
    The rising relative and absolute incidence of uterine cancer in specific populations.
    Int J Gynaecol Obstet. 2020 Feb 29. doi: 10.1002/ijgo.13130.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.